Skip to main content
Top
Published in: BMC Health Services Research 1/2010

Open Access 01-12-2010 | Research article

Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China

Authors: Weibing Wang, Chaowei Fu, Haijing Zhuo, Jianfeng Luo, Biao Xu

Published in: BMC Health Services Research | Issue 1/2010

Login to get access

Abstract

Background

Type 2 Diabetes mellitus (T2DM) affects persons of all ages, while also placing heavy economic burdens on national economies and healthcare systems. The study aims to investigate the determinants of direct medical cost (DMC), out-of-pocket (OOP) proportion of the cost, and healthcare utilization associated with T2DM.

Methods

This cross-sectional study was conducted in four major cities in China. Eligible subjects were adult outpatients who received treatment at one of 15 sampled secondary or tertiary hospitals and consecutively enrolled between March 2007 and May 2007. Generalized estimating equations were used to determine impact factors associated with DMC and healthcare utilization.

Results

Insurance schemes and receiving insulin therapy were significantly associated with a higher annual DMC of T2DM. For each increase in number of complications, there was about 33% increase in annual DMC. Insurance schemes were significantly associated with the proportions of DMC from pocket. A 7% significantly lower proportion of DMC was paid and 23% more clinic visits (AOR = 1.232, P < 0.001) were made by patients admitted at secondary hospitals than tertiary hospitals. The group with higher income (> 2000 CNY/month) paid 23% less from their pocket, compared with the lower income group. The number of complications also significantly increased the outpatient visits (AOR = 1.064, P < 0.001).

Conclusions

It implies that preventing complications through the use of more effective treatment regimens is important in order to control the healthcare expenditures of the diseases. Healthcare reform needs to be focused on the medical insurance system and redistribution of patients in hospitals of different levels.
Literature
1.
go back to reference International Diabetes Federation: Diabetes atlas. 2006, Brussels: IDF, 3 International Diabetes Federation: Diabetes atlas. 2006, Brussels: IDF, 3
2.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362 (12): 1090-1101. 10.1056/NEJMoa0908292.CrossRefPubMed
3.
go back to reference Qi X, Wang Y: Report on Chronic Disease in China. 2006, Beijing: China National Center for Disease Control and Prevention Qi X, Wang Y: Report on Chronic Disease in China. 2006, Beijing: China National Center for Disease Control and Prevention
4.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
5.
go back to reference Jamison DT, World Bank., Disease Control Priorities Project: Disease control priorities in developing countries. 2006, New York & Washington, DC: Oxford University Press; World Bank, 2 Jamison DT, World Bank., Disease Control Priorities Project: Disease control priorities in developing countries. 2006, New York & Washington, DC: Oxford University Press; World Bank, 2
6.
go back to reference Wang W, Fu CW, Pan CY, Chen W, Zhan S, Luan R, Tan A, Liu Z, Xu B: How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?. Value Health. 2009, 12 (6): 923-929. 10.1111/j.1524-4733.2009.00561.x.CrossRefPubMed Wang W, Fu CW, Pan CY, Chen W, Zhan S, Luan R, Tan A, Liu Z, Xu B: How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?. Value Health. 2009, 12 (6): 923-929. 10.1111/j.1524-4733.2009.00561.x.CrossRefPubMed
7.
go back to reference Brown JB, Nichols GA, Glauber HS, Bakst AW: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care. 1999, 22 (7): 1116-1124. 10.2337/diacare.22.7.1116.CrossRefPubMed Brown JB, Nichols GA, Glauber HS, Bakst AW: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care. 1999, 22 (7): 1116-1124. 10.2337/diacare.22.7.1116.CrossRefPubMed
8.
go back to reference Williams R, Van Gaal L, Lucioni C: Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002, 45 (7): S13-17.CrossRefPubMed Williams R, Van Gaal L, Lucioni C: Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002, 45 (7): S13-17.CrossRefPubMed
9.
go back to reference Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH: The direct medical cost of type 2 diabetes. Diabetes Care. 2003, 26 (8): 2300-2304. 10.2337/diacare.26.8.2300.CrossRefPubMed Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH: The direct medical cost of type 2 diabetes. Diabetes Care. 2003, 26 (8): 2300-2304. 10.2337/diacare.26.8.2300.CrossRefPubMed
10.
go back to reference Gilmer TP, O'Connor PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care. 1997, 20 (12): 1847-1853. 10.2337/diacare.20.12.1847.CrossRefPubMed Gilmer TP, O'Connor PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care. 1997, 20 (12): 1847-1853. 10.2337/diacare.20.12.1847.CrossRefPubMed
11.
go back to reference UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352 (9131): 837-853. 10.1016/S0140-6736(98)07019-6.CrossRef UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352 (9131): 837-853. 10.1016/S0140-6736(98)07019-6.CrossRef
12.
go back to reference Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI: Predictors of health care costs in adults with diabetes. Diabetes Care. 2005, 28 (1): 59-64. 10.2337/diacare.28.1.59.CrossRefPubMed Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI: Predictors of health care costs in adults with diabetes. Diabetes Care. 2005, 28 (1): 59-64. 10.2337/diacare.28.1.59.CrossRefPubMed
13.
go back to reference Goldman DP, Joyce GF, Zheng Y: Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007, 298 (1): 61-69. 10.1001/jama.298.1.61.CrossRefPubMed Goldman DP, Joyce GF, Zheng Y: Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007, 298 (1): 61-69. 10.1001/jama.298.1.61.CrossRefPubMed
14.
go back to reference Fox KM, Group SG: Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus. Curr Med Res Opin. 2008, 24 (12): 3323-9. 10.1185/03007990802520045.CrossRefPubMed Fox KM, Group SG: Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus. Curr Med Res Opin. 2008, 24 (12): 3323-9. 10.1185/03007990802520045.CrossRefPubMed
15.
go back to reference Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, Everson-Stewart S, Kinder L, Oliver M, Boyko EJ, et al: Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008, 14 (1): 15-23.PubMedPubMedCentral Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, Everson-Stewart S, Kinder L, Oliver M, Boyko EJ, et al: Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008, 14 (1): 15-23.PubMedPubMedCentral
16.
go back to reference Chaikledkaew U, Pongchareonsuk P, Chaiyakunapruk N, Ongphiphadhanakul B: Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals. Value Health. 2008, 11 (Suppl 1): S69-74. 10.1111/j.1524-4733.2008.00369.x.CrossRefPubMed Chaikledkaew U, Pongchareonsuk P, Chaiyakunapruk N, Ongphiphadhanakul B: Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals. Value Health. 2008, 11 (Suppl 1): S69-74. 10.1111/j.1524-4733.2008.00369.x.CrossRefPubMed
17.
go back to reference Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR: Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Med Care. 2008, 46 (6): 565-572. 10.1097/MLR.0b013e3181734a77.CrossRefPubMed Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR: Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Med Care. 2008, 46 (6): 565-572. 10.1097/MLR.0b013e3181734a77.CrossRefPubMed
18.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15 (7): 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15 (7): 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
19.
go back to reference Chan BS, Tsang MW, Lee VW, Lee KK: Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. Int J Clin Pharmacol Ther. 2007, 45 (8): 455-468.CrossRefPubMed Chan BS, Tsang MW, Lee VW, Lee KK: Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. Int J Clin Pharmacol Ther. 2007, 45 (8): 455-468.CrossRefPubMed
20.
go back to reference Rathmann W, Haastert B, Roseman JM, Gries FA, Giani G: Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care. 1998, 21 (3): 389-397. 10.2337/diacare.21.3.389.CrossRefPubMed Rathmann W, Haastert B, Roseman JM, Gries FA, Giani G: Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care. 1998, 21 (3): 389-397. 10.2337/diacare.21.3.389.CrossRefPubMed
21.
go back to reference Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Gortz A: [Costs of type 2 diabetes in Germany. Results of the CODE-2 study]. Dtsch Med Wochenschr. 2001, 126 (20): 585-589. 10.1055/s-2001-14102.CrossRefPubMed Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Gortz A: [Costs of type 2 diabetes in Germany. Results of the CODE-2 study]. Dtsch Med Wochenschr. 2001, 126 (20): 585-589. 10.1055/s-2001-14102.CrossRefPubMed
22.
go back to reference American-Diabetes-Association: Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008, 31 (3): 596-615. 10.2337/dc08-9017.CrossRef American-Diabetes-Association: Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008, 31 (3): 596-615. 10.2337/dc08-9017.CrossRef
23.
go back to reference Geyman JP: Moral hazard and consumer-driven health care: a fundamentally flawed concept. Int J Health Serv. 2007, 37 (2): 333-351. 10.2190/J354-150M-NG76-7340.CrossRefPubMed Geyman JP: Moral hazard and consumer-driven health care: a fundamentally flawed concept. Int J Health Serv. 2007, 37 (2): 333-351. 10.2190/J354-150M-NG76-7340.CrossRefPubMed
24.
go back to reference Xu L, Wang Y, Collins CD, Tang S: Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. BMC Health Serv Res. 2007, 7: 37-10.1186/1472-6963-7-37.CrossRefPubMedPubMedCentral Xu L, Wang Y, Collins CD, Tang S: Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. BMC Health Serv Res. 2007, 7: 37-10.1186/1472-6963-7-37.CrossRefPubMedPubMedCentral
25.
go back to reference Ross JS, Bradley EH, Busch SH: Use of health care services by lower-income and higher-income uninsured adults. JAMA. 2006, 295 (17): 2027-2036. 10.1001/jama.295.17.2027.CrossRefPubMed Ross JS, Bradley EH, Busch SH: Use of health care services by lower-income and higher-income uninsured adults. JAMA. 2006, 295 (17): 2027-2036. 10.1001/jama.295.17.2027.CrossRefPubMed
26.
go back to reference Pagan JA, Puig A, Soldo BJ: Health insurance coverage and the use of preventive services by Mexican adults. Health Econ. 2007, 16 (12): 1359-1369. 10.1002/hec.1226.CrossRefPubMed Pagan JA, Puig A, Soldo BJ: Health insurance coverage and the use of preventive services by Mexican adults. Health Econ. 2007, 16 (12): 1359-1369. 10.1002/hec.1226.CrossRefPubMed
27.
go back to reference Ministry of Health: Study on National Health Services in 2003. 2004, Beijing: Ministry of Health, China Ministry of Health: Study on National Health Services in 2003. 2004, Beijing: Ministry of Health, China
28.
go back to reference Zuo Y, Hu S, Fu W: A study on New Cooperative Medical Scheme in China. Chinese Health Resources. 2006, 9 (3): 127-129. Zuo Y, Hu S, Fu W: A study on New Cooperative Medical Scheme in China. Chinese Health Resources. 2006, 9 (3): 127-129.
29.
go back to reference China National Health Economics Institute: China national health accounts report 2005. 2005, Beijing: China National Health Economics Institute China National Health Economics Institute: China national health accounts report 2005. 2005, Beijing: China National Health Economics Institute
30.
go back to reference Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, de Ferranti D: Reform of how health care is paid for in China: challenges and opportunities. Lancet. 2008, 372 (9652): 1846-1853. 10.1016/S0140-6736(08)61368-9.CrossRefPubMed Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, de Ferranti D: Reform of how health care is paid for in China: challenges and opportunities. Lancet. 2008, 372 (9652): 1846-1853. 10.1016/S0140-6736(08)61368-9.CrossRefPubMed
31.
go back to reference Liu GG, Zhao Z: Urban employee health insurance reform and the impact on out-of-pocket payment in China. Int J Health Plann Manage. 2006, 21 (3): 211-228. 10.1002/hpm.846.CrossRefPubMed Liu GG, Zhao Z: Urban employee health insurance reform and the impact on out-of-pocket payment in China. Int J Health Plann Manage. 2006, 21 (3): 211-228. 10.1002/hpm.846.CrossRefPubMed
32.
go back to reference Guo Y, Shibuya K, Cheng G, Rao K, Lee L, Tang S: Tracking China's health reform. Lancet. 2010, 375 (9720): 1056-1058. 10.1016/S0140-6736(10)60397-2.CrossRefPubMed Guo Y, Shibuya K, Cheng G, Rao K, Lee L, Tang S: Tracking China's health reform. Lancet. 2010, 375 (9720): 1056-1058. 10.1016/S0140-6736(10)60397-2.CrossRefPubMed
33.
go back to reference Du L: A Summary Analysis and some Policy Suggestion of the Flows of Total Health Expenditure in China. Chinese Health Economics. 2008, 299 (1): 19-20. Du L: A Summary Analysis and some Policy Suggestion of the Flows of Total Health Expenditure in China. Chinese Health Economics. 2008, 299 (1): 19-20.
34.
go back to reference Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA. 2001, 285 (2): 182-189. 10.1001/jama.285.2.182.CrossRefPubMed Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA. 2001, 285 (2): 182-189. 10.1001/jama.285.2.182.CrossRefPubMed
Metadata
Title
Factors affecting costs and utilization of type 2 diabetes healthcare: a cross-sectional survey among 15 hospitals in urban China
Authors
Weibing Wang
Chaowei Fu
Haijing Zhuo
Jianfeng Luo
Biao Xu
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2010
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-10-244

Other articles of this Issue 1/2010

BMC Health Services Research 1/2010 Go to the issue